ARCHIVES

Revlimid Maintenance Therapy Delayed Progression by 90%

This article is from The Cancer Letter archive.

Vol. 34 No. 5 | May 27, 2011

Download PDF Visit The Full Archive

Related Articles

NIH Inquiry Finds No Impropriety In Treatment of Teddy DeVita

April 9, 1976

NCCS Networker Volume 3 Issue 4, Fall 1989

September 13, 1989

NCI Unconventional Innovations Program releases Broad Agency Announcement.

October 24, 2003

Oral Therapy Sorafenib Improves Survival Of Advanced Liver Cancer In Study

June 29, 2007

NCI To Seek Proposals For Less Invasive Detection, Diagnosis, Treatment Technologies

July 3, 1998

Worker Health RFA May Finally Be Ready

August 26, 1988